Disease / condition

Covid19 clinical trials

Free access to 950 studies·10+ countries·Updated daily333 recruiting
950
Total trials
10+
Countries
10+
Sponsors
333
Recruiting
By phase
N/A561
Phase 2132
Phase 392
Phase 150
Phase 2/339
By status
Recruiting333
Completed289
Not yet recruit...210
Withdrawn31
Enrolling by in...30
Top countries
United States of America207
France78
Egypt51
Turkey41
Italy40
Top sponsors
Assiut University25
Sorrento Therapeut...12
Assistance Publiqu...11
Stanford Universit...9
University of Penn...9
Recent trials
Latest clinical trials for Covid19
NCT06321367Completed
Model to Predict Coinfection in Elderly Patients With COVID-19
Xiangya Hospital of Central So...China
NCT06158724Withdrawn
COVID-19 Personal Protective Equipment for Vaccinated Health Workers and Convalescents
University Medical Centre Ljub...Slovenia
NCT06042855·Phase 3Recruiting
ACTIV-6: COVID-19 Study of Repurposed Medications - Arm G (Metformin)
Susanna Naggie, MDUnited States of America
NCT06012565·Phase 2Terminated
KAND567 Versus Placebo in Subjects Hospitalized With COVID-19
Kancera ABDenmark,Sweden
NCT05894577·Phase 3Not yet recr...
ACTIV-6: COVID-19 Study of Repurposed Medications - Arm F (Montelukast)
Susanna Naggie, MDUnited States of America
NCT05894538·Phase 3Completed
ACTIV-6: COVID-19 Study of Repurposed Medications - Arm D (Ivermectin 600)
Susanna Naggie, MDUnited States of America
NCT05894564·Phase 3Completed
ACTIV-6: COVID-19 Study of Repurposed Medications - Arm E (Fluvoxamine 100)
Susanna Naggie, MDUnited States of America
NCT05890586·Phase 3Completed
ACTIV-6: COVID-19 Study of Repurposed Medications - Arm B (Fluvoxamine)
Susanna Naggie, MDUnited States of America
NCT05777720Enrolling by...
Cluster-Randomized Trial of Air Filtration and Ventilation to Reduce Covid19 Spread in Homes
Stanford UniversityUnited States of America
NCT05736861·Phase 3Completed
ACTIV-6: COVID-19 Study of Repurposed Medications - Arm A (Ivermectin 400)
Susanna Naggie, MDUnited States of America
NCT05736874·Phase 3Completed
ACTIV-6: COVID-19 Study of Repurposed Medications - Arm C (Fluticasone)
Susanna Naggie, MDUnited States of America
NCT05659615Recruiting
Analysis of Breathing Pattern Post COVID-19
Shirley Lima CamposBrazil
NCT05548803Enrolling by...
COVID-19 Citizen Science Expansion Project
University of California, San ...United States of America
NCT05493410Completed
EFFECTS OF INSPIRATORY MUSCLE TRAINING IN POST-COVID-19 PATIENTS
University Vila VelhaBrazil
NCT05280717·Phase 1Recruiting
Relative Bioavailability, Safety, and Tolerability of Single-dose Sotrovimab Injection in Adults (COSMIC)
Vir Biotechnology, Inc.United States of America
NCT05200741·Phase 2Recruiting
To Evaluate Safety & Immunogenicity of DelNS1-2019-nCoV-RBD-OPT1 for COVID-19 in Healthy Adults Received 2 Doses of BNT162b2
The University of Hong KongChina
NCT05197725Withdrawn
Face Masks to Reduce SARS-CoV-2 Infections (COVID-19) in Bangladesh
Yale UniversityBangladesh
NCT05235347No longer av...
Sotrovimab Expanded Access Treatment Protocol (COVID-19)
Vir Biotechnology, Inc.United States of America
NCT05191420Recruiting
Conversations You Want About Corona Virus Disease (COVID-19)
Wake Forest University Health ...United States of America
NCT05172037·Phase 3Recruiting
Novaferon in Non-hospitalized Adult Patients With Mild COVID-19
Genova Inc.Japan
About this record

Access comprehensive clinical trial information for Covid19 through Pure Global AI's free database. This collection includes 950 clinical trials across multiple phases including N/A, Phase 2, Phase 3. Currently, 333 trials are actively recruiting participants.

Research for Covid19 is being conducted in United States of America, France, Egypt and 7+ other countries. Leading sponsors include Assiut University and Sorrento Therapeutics, Inc.. Pure Global AI offers free access to clinical trial data from ClinicalTrials.gov, WHO ICTRP, and regional registries worldwide.

Pure Global AI provides free access to 950 clinical trials studying Covid19, aggregated from major global registries including ClinicalTrials.gov, WHO ICTRP, and regional databases.

The trials span multiple phases, from early Phase 1 safety studies to large-scale Phase 3 efficacy trials, conducted across 10+ countries.

Top research sponsors include Assiut University, Sorrento Therapeutics, Inc., Assistance Publique - Hôpitaux de Paris, among others.